We are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page, or call 1-877-436-3683. See the latest update on Actemra® (tocilizumab) supply here.

FAQs for Current Suppliers

Notice for Suppliers

We have recently updated our Invoice Rejection policy. More information on invoice rejections and our procurement & payment processes can be found here.

Getting Started

Invoices & Payments